Latest Breaking News On - பெஞ்சமின் கோலிங் - Page 4 : comparemela.com

South China Morning Post A new Hong Kong study has found that recipients of the BioNTech Covid-19 vaccine have 10 times more antibodies than those who took Sinovac, with the latter generating levels of the virus-targeting proteins that were similar or lower than the naturally occurring ones seen in recovered patients. The findings by the University of Hong Kong, published in Lancet Microbe on Friday (July 16), could suggest the need for alternative strategies - including booster shots - to increase Sinovac recipients antibody concentrations and protection against Covid-19, according to the researchers. The presence of antibodies is a sign of a previous infection, or that a vaccine is working to protect an individual, but the quantity of the proteins generated by the body to identify and neutralise the coronavirus does not directly correlate to the level of immunity.

Hong kongUniversity of hong kongHong kong generalGabriel leungBiontech covidBenjamin cowlingMalik peirisCentre for health protectionLancet microbeHealth protectionHong kong sanatoriumHong kong medical journalஹாங் காங்பல்கலைக்கழகம் ஆஃப் ஹாங் காங்கேப்ரியல் லேஉங்பெஞ்சமின் கோலிங்